Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02032368|
Recruitment Status : Completed
First Posted : January 10, 2014
Last Update Posted : January 10, 2014
|Condition or disease||Intervention/treatment||Phase|
|Circulating Tumor Cell; Hepatocellular Carcinoma||Procedure: transarterial chemoembolization (TACE)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||57 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence|
|Study Start Date :||July 2010|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||December 2012|
Experimental: TACE group
Patients in TACE group receive transarterial chemoembolization (TACE) one month after resection.
Procedure: transarterial chemoembolization (TACE)
No Intervention: Control group
Patients in Control group receive no management.
- Change of circulating tumor cell(CTC) count at different timepoints [ Time Frame: time before TACE and time after TACE ]The time points for blood collection to count CTC were1)one day before TACE(also one month after resection);2)three days after TACE;3)one month after TACE;4) two months after TACE;5)three months after TACE;6)six months after TACE;7) one year after TACE.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02032368
|Department of Interventional Radiology; Cancer Center; Guangdong General Hospital|
|Guangzhou, Guangdong, China|